Margaretha HaeusslerExecutive Director, Transfer Pricing at NOVARTIS
Agenda Sessions
Transfer Pricing Aspects of Pillar 2
, 11:25amView SessionAmount B/Simplified and Streamlined Approach – Global Roundup & Status Update
, 1:20pmView SessionSuccessful Approaches to Valuation of IP
, 3:15pmView Session